Pharming (PHAR) Leases (2019 - 2025)
Historic Leases for Pharming (PHAR) over the last 7 years, with Q3 2025 value amounting to $17.5 million.
- Pharming's Leases fell 2028.67% to $17.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $17.5 million, marking a year-over-year decrease of 2028.67%. This contributed to the annual value of $16.4 million for FY2024, which is 3110.15% down from last year.
- As of Q3 2025, Pharming's Leases stood at $17.5 million, which was down 2028.67% from $16.6 million recorded in Q2 2025.
- Pharming's Leases' 5-year high stood at $30.4 million during Q1 2023, with a 5-year trough of $8828.0 in Q1 2021.
- Over the past 5 years, Pharming's median Leases value was $21.0 million (recorded in 2021), while the average stood at $18.7 million.
- Data for Pharming's Leases shows a peak YoY increase of 22001780.7% (in 2022) and a maximum YoY decrease of 9991.91% (in 2022) over the last 5 years.
- Quarter analysis of 5 years shows Pharming's Leases stood at $20129.3 in 2021, then surged by 142741.42% to $28.8 million in 2022, then fell by 17.31% to $23.8 million in 2023, then crashed by 31.1% to $16.4 million in 2024, then increased by 6.93% to $17.5 million in 2025.
- Its last three reported values are $17.5 million in Q3 2025, $16.6 million for Q2 2025, and $16.5 million during Q1 2025.